1,677
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Preparation, characterization, and in vitro/vivo evaluation of dexamethasone/poly(ε-caprolactone)-based electrode coatings for cochlear implants

, , , , , & ORCID Icon show all
Pages 1673-1684 | Received 13 Jun 2021, Accepted 21 Jul 2021, Published online: 04 Aug 2021

References

  • Astolfi L, Guaran V, Marchetti N, et al. (2014). Cochlear implants and drug delivery: in vitro evaluation of dexamethasone release. J Biomed Mater Res B Appl Biomater 102:267–73.
  • Astolfi L, Simoni E, Giarbini N, et al. (2016). Cochlear implant and inflammation reaction: safety study of a new steroid-eluting electrode. Hear Res 336:44–52.
  • Bas E, Bohorquez J, Goncalves S, et al. (2017). Electrode array-eluted dexamethasone protects against electrode insertion trauma induced hearing and hair cell losses, damage to neural elements, increases in impedance and fibrosis: a dose response study. Hear Res 350:45–57.
  • Bas E, Dinh CT, Garnham C, et al. (2012). Conservation of hearing and protection of hair cells in cochlear implant patients' with residual hearing. Anat Rec 295:1909–27.
  • Ceschi P, Bohl A, Sternberg K, et al. (2014). Biodegradable polymeric coatings on cochlear implant surfaces and their influence on spiral ganglion cell survival. J Biomed Mater Res B Appl Biomater 102:1255–67.
  • Chandrasekhar SS. (2001). Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 22:18–23.
  • Daldal A, Odabasi O, Serbetcioglu B. (2007). The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs. Otolaryngol Head Neck Surg 137:747–52.
  • De Ceulaer G, Johnson S, Yperman M, et al. (2003). Long-term evaluation of the effect of intracochlear steroid deposition on electrode impedance in cochlear implant patients. Otol Neurotol 24:769–74.
  • Eftekhari A, Dizaj SM, Sharifi S, et al. (2020). The use of nanomaterials in tissue engineering for cartilage regeneration; current approaches and future perspectives. Int J Mol Sci 21(2):536.
  • Enticott JC, Eastwood HT, Briggs RJ, et al. (2011). Methylprednisolone applied directly to the round window reduces dizziness after cochlear implantation: a randomized clinical trial. Audiol Neurootol 16:289–303.
  • Eshraghi AA, Adil E, He J, et al. (2007). Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-induced hearing loss. Otol Neurotol 28:842–9.
  • Farhadi M, Jalessi M, Salehian P, et al. (2013). Dexamethasone eluting cochlear implant: histological study in animal model. Cochlear Implants Int 14:45–50.
  • Fayad JN, Makarem AO, Linthicum FH Jr. (2009). Histopathologic assessment of fibrosis and new bone formation in implanted human temporal bones using 3D reconstruction. Otolaryngol Head Neck Surg 141:247–52.
  • Himeno C, Komeda M, Izumikawa M, et al. (2002). Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res 167:61–70.
  • Jia H, Venail F, Piron JP, et al. (2011). Effect of surgical technique on electrode impedance after cochlear implantation. Ann Otol Rhinol Laryngol 120:529–34.
  • Jia H, François F, Bourien J, et al. (2016). Prevention of trauma-induced cochlear fibrosis using intracochlear application of anti-inflammatory and antiproliferative drugs. Neuroscience 316:261–78.
  • Jia H, Wang J, Francois F, et al. (2013). Molecular and cellular mechanisms of loss of residual hearing after cochlear implantation. Ann Otol Rhinol Laryngol 122:33–9.
  • Kather M, Koitzsch S, Breit B, et al. (2021). Metabolic reprogramming of inner ear cell line HEI-OC1 after dexamethasone application. Metabolomics 17.6:1–10.
  • Kiefer J, Gstoettner W, Baumgartner W, et al. (2004). Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngol 124:272–80.
  • Kikkawa YS, Nakagawa T, Ying L, et al. (2014). Growth factor-eluting cochlear implant electrode: impact on residual auditory function, insertional trauma, and fibrosis. J Transl Med 12:280.
  • Lee J, Ismail H, Lee JH, et al. (2013). Effect of both local and systemically administered dexamethasone on long-term hearing and tissue response in a Guinea pig model of cochlear implantation. Audiol Neurootol 18:392–405.
  • Liu Y, Jolly C, Braun S, et al. (2015). Effects of a dexamethasone-releasing implant on cochleae: a functional, morphological and pharmacokinetic study. Hear Res 327:89–101.
  • Mondrinos MJ, Dembzynski R, Lu L, et al. (2006). Porogen-based solid freeform fabrication of polycaprolactone-calcium phosphate scaffolds for tissue engineering. Biomaterials 27:4399–408.
  • Nair LS, Laurencin CT. (2007). Biodegradable polymers as biomaterials. Prog Polym Sci 32:762–98.
  • O'Leary SJ, Monksfield P, Kel G, et al. (2013). Relations between cochlear histopathology and hearing loss in experimental cochlear implantation. Hear Res 298:27–35.
  • Paasche G, Tasche C, Stover T, et al. (2009). The long-term effects of modified electrode surfaces and intracochlear corticosteroids on postoperative impedances in cochlear implant patients. Otol Neurotol 30:592–8.
  • Richardson RT, Wise AK, Thompson BC, et al. (2009). Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials 30:2614–24.
  • Rohner D, Hutmacher D, See P, et al. (2002). Individually CAD-CAM technique designed, bioresorbable 3-dimensional polycaprolactone framework for experimental reconstruction of craniofacial defects in the pig. Mund Kiefer Gesichtschir 6:162–7.
  • Seregin VV, Coffer JL. (2006). Biomineralization of calcium disilicide in porous polycaprolactone scaffolds. Biomaterials 27:4745–54.
  • Stathopoulos D, Chambers S, Enke YL, et al. (2014). Development of a safe dexamethasone-eluting electrode array for cochlear implantation. Cochlear Implants Int 15:254–63.
  • Sun HF, Mei L, Song CX, et al. (2006). The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials 27:1735–40.
  • Tabuchi K, Oikawa K, Murashita H, et al. (2006). Protective effect of glucocorticoids on ischemia-reperfusion injury of outer hair cells. Laryngoscope 116:627–9.
  • Takemura K, Komeda M, Yagi M, et al. (2004). Direct inner ear infusion of dexamethasone attenuates noise-induced trauma in the Guinea pig. Hear. Res 196:56–68.
  • Tanaka C, Nguyen-Huynh A, Loera K, et al. (2014). Factors associated with hearing loss in a normal-hearing guinea pig model of hybrid cochlear implants. Hear Res 316:82–93.
  • Teoh SH, Tan KC, Hutmacher D, et al. (2004). Bioabsorbable plug implants and method for bone tissue regeneration. U.S. Patent Application 10/579,946.
  • Turner CW, Reiss LA, Gantz BJ. (2008). Combined acoustic and electric hearing: preserving residual acoustic hearing. Hear Res 242:164–71.
  • Vivero RJ, Joseph DE, Angeli S, et al. (2008). Dexamhetasone base conserves hearing from electrode trauma-induced hearing loss. Laryngoscope 118:2028–35.
  • Woodruff MA, Hutmacher DW. (2010). The return of a forgotten polymer—polycaprolactone in the 21st century. Prog Polym Sci 35:1217–56.
  • Xu M, Ma D, Chen D, et al. (2018). Preparation, characterization and application research of a sustained dexamethasone releasing electrode coating for cochlear implantation. Mater Sci Eng C Mater Biol Appl 90:16–26.
  • Zou J, Pyykko I, Sutinen P, Toppila E. (2005). Vibration induced hearing loss in guinea pig cochlea: expression of TNF-alpha and VEGF. Hear Res 202:13–20.